Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2021
Defence Therapeutics appoints Riam Shammaa to its board
Defence Therapeutics announced the appointment of Dr. Riam Shammaa to its board of directors, effective immediately.
2021
Defence Therapeutics and Curie Institute establish collaboration
Defence Therapeutics announced a collaboration with the Curie Institute to evaluate Accum-T-DM1 ADC's therapeutic efficacy in patient-derived xenograft models of breast cancer.